The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
A Clinical Trial of Progesterone for Severe Traumatic Brain Injury
Open accessAbstract
BACKGROUND: Progesterone has been associated with robust positive effects in animal models of traumatic brain injury (TBI) and with clinical benefits in two phase 2 randomized, controlled trials. We investigated the efficacy and safety of progesterone in a large, prospective, phase 3 randomized clinical trial. METHODS: We conducted a multinational placebo-controlled trial, in which 1195 patients, 16 to 70 years of age, with severe TBI (Glasgow Coma Scale score, ≤8 [on a scale of 3 to 15, with lower scores indicating a reduced level of consciousness] and at least one reactive pupil) were randomly assigned to receive progesterone or placebo. Dosing began within 8 hours after injury and continued for 120 hours. The primary efficacy end point was the Glasgow Outcome Scale score at 6 months after the injury. RESULTS: Proportional-odds analysis with covariate adjustment showed no treatment effect of progesterone as compared with placebo (odds ratio, 0.96; confidence interval, 0.77 to 1.18). The proportion of patients with a favorable outcome on the Glasgow Outcome Scale (good recovery or moderate disability) was 50.4% with progesterone, as compared with 50.5% with placebo. Mortality was similar in the two groups. No relevant safety differences were noted between progesterone and placebo. CONCLUSIONS: Primary and secondary efficacy analyses showed no clinical benefit of progesterone in patients with severe TBI. These data stand in contrast to the robust preclinical data and results of early single-center trials that provided the impetus to initiate phase 3 trials. (Funded by BHR Pharma; SYNAPSE ClinicalTrials.gov number, NCT01143064.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Currently, no readily available treatment has proven to be effective for preventing or reversing the BBB damage after TBI in the clinical setting.”
From Increased miR-21-3p in Injured Brain Microvascular Endothelial Cells after Traumatic Brain Injury Aggravates Blood–Brain Barrier Damage by Promoting Cellular Apoptosis and Inflammation through Targeting MAT2B (2019) · cites this paper as [15]
Experimental — accuracy not yet measuredIn the citing paper
“Finally, the disappointing results of progesterone in Phase III clinical trials has called into question the importance of sex hormones in determining TBI outcome. 73,74”
From Sex Differences in Traumatic Brain Injury: What We Know and What We Should Know (2019) · cites this paper as [73]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
National Center for Injury Prevention and Control (U.S.). Division of Injury Response., Faul, M., Wald, M. M., Wu, L., & Coronado, V. G. (2010) · doi:10.15620/cdc.5571 · Cited by 3,494
Ghajar, J. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02689-1 · Cited by 2,244
Moderate and severe traumatic brain injury in adults
Maas, A. I., Stocchetti, N., & Bullock, R. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70164-9 · Cited by 2,123
Self-citationChanging patterns in the epidemiology of traumatic brain injury
Roozenbeek, B., Maas, A. I. R., & Menon, D. K. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.22 · Cited by 1,405
Self-citationA new classification of head injury based on computerized tomography
Marshall, L. F., Marshall, S. B., Klauber, M. R., van Berkum-Clark, M., Eisenberg, H. M., Jane, J. A., Luerssen, T. G., Marmarou, A., & Foulkes, M. A. (1991) · Journal of neurosurgery · doi:10.3171/sup.1991.75.1s.0s14 · Cited by 1,327
Classification of traumatic brain injury for targeted therapies
Saatman, K. E., Duhaime, A.-C., Bullock, R., Maas, A. I. R., Valadka, A., & Manley, G. T. (2008) · Journal of Neurotrauma · doi:10.1089/neu.2008.0586 · Cited by 1,141
Self-citationClinical trials in head injury
Narayan, R. K., Michel, M. E., Ansell, B., Baethmann, A., Biegon, A., Bracken, M. B., Bullock, M. R., Choi, S. C., Clifton, G. L., Contant, C. F., et al. (2002) · Journal of Neurotrauma · doi:10.1089/089771502753754037 · Cited by 913
Self-citationProTECT: A Randomized Clinical Trial of Progesterone for Acute Traumatic Brain Injury
Wright, D. W., Kellermann, A. L., Hertzberg, V., Clark, P. L., Frankel, M., Goldstein, F. C., Salomone, J. P., Dent, L. L., Harris, O. A., Ander, D. S., et al. (2006) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2006.07.932 · Cited by 599
Very Early Administration of Progesterone for Acute Traumatic Brain Injury
Wright, D. W., Yeatts, S. D., Silbergleit, R., Palesch, Y. Y., Hertzberg, V. S., Frankel, M., Goldstein, F. C., Caveney, A. F., Howlett-Smith, H., Bengelink, E. M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1404304 · Cited by 567
Xiao, G., Wei, J., Yan, W., Wang, W., & Lu, Z. (2008) · Critical Care · doi:10.1186/cc6887 · Cited by 463
Flagged first, then by citations
Research works printed but not linked: 3
- He J, 2004, Restor Neurol Neurosci, 22, 19
- Morris GF, 1998, Neurosurgery, 43, 1369
- 10.1089/neu.2008.0794 · DOI · Paper page
Cited by
Sorted by citations
Items 501–509 of 509
Perspectiva de sexo y género en Medicina Intensiva. Una deuda pendiente
Gutiérrez-Gutiérrez, J. (2026) · Medicina Intensiva · doi:10.1016/j.medin.2026.502620
Futhey, N. C., Bird, J. D., Neumar, R. W., Robba, C., Olasveengen, T. M., Steele, A. R., Cembrowski, M. S., Hirsch‐Reinshagen, V., & Sekhon, M. S. (2026) · Resuscitation · doi:10.1016/j.resuscitation.2026.111336
Entwistle, T. R., Cowey, W. R., Stokoe, E., Stone, J. P., & Fildes, J. E. (2026) · PLoS ONE · doi:10.1371/journal.pone.0358773
Endocrine therapies and hormonal dysfunction after traumatic brain injury: A scoping review
Smith, C., Zhang, Z., Ranganathan, S., & Yuen, K. C. J. (2026) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2026.101728
Sharratt, C. A., Hall, J. L., Crack, P. J., & Tan, H. X. (2026) · Pharmaceuticals · doi:10.3390/ph19101659
Sun, M., Li, S., He, Z., Xie, J., Luo, Y., Fan, X., Zhang, J., Qin, L., Peng, L., Qiu, T., et al. (2026) · Advanced Science · doi:10.1002/advs.78308
Sex and gender perspective in Intensive Care Medicine. An outstanding issue
Gutiérrez-Gutiérrez, J. (2026) · Medicina Intensiva (English Edition) · doi:10.1016/j.medine.2026.502620
Yun, Y., Jena, S., Egido-Betancourt, H., Uzoechi, S., Kim, D. Y., Lee, J.-M., & Nguyen, J. (2026) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2026.115982
Omics-guided therapeutic translation in acute traumatic brain injury
Nynatten, L. R. V., Cela, E., Wilson, A., Ball, I. M., & Fraser, D. D. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1968318
Metadata
- Authors
- Skolnick, B. E., Maas, A. I., Narayan, R. K., van der Hoop, R. G., MacAllister, T., Ward, J. D., Nelson, N. R., & Stocchetti, N.
- Affiliations
- Hofstra University (US)
- University of Antwerp (BE)
- Virginia Commonwealth University (US)
- University of Milan (IT)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2014-12-25
- Volume
- 371
- Issue
- 26
- Pages
- 2467-2476
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2046037876
- Cited by
- 505
- References
- 29
- Citations by year
- 2026: 40 · 2025: 25 · 2024: 25 · 2023: 18 · 2022: 44 · 2021: 36 · 2020: 46 · 2019: 46 · 2018: 49 · 2017: 56 · 2016: 67 · 2015: 50 · 2014: 1
- FWCI
- 37.61
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Tampere University Institutional Repository (Tampere University) (publishedVersion)
- BOA (University of Milano-Bicocca) (submittedVersion)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- Tampere University Institutional Repository (Tampere University) (submittedVersion)
- Funders
- Universitair Ziekenhuis Antwerpen
- Topics
- Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury and Neurovascular Disturbances
- Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury Research
- Health Sciences › Medicine › Emergency Medicine › Trauma and Emergency Care Studies
- Keywords
- progesterone, severe traumatic brain injury, Glasgow Outcome Scale, treatment efficacy, drug safety, neuroprotection
- MeSH terms
- Adolescent, Adult, Aged, Brain Injuries, Double-Blind Method, Drug Administration Schedule, Female, Humans, Infusions, Intravenous, Male, Middle Aged, Progesterone, Glasgow Coma Scale, Odds Ratio, Treatment Failure, Glasgow Outcome Scale, Young Adult, Intention to Treat Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
